Depomed (DEPO) Tops Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DEPO Hot Sheet
Price: $7.30 --0%
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Financial Fact:
Total costs and expenses: 109.27M
Today's EPS Names:
EGRX, VAXX, AFIB, More
Join SI Premium – FREE
Depomed (NASDAQ: DEPO) reported Q2 EPS of $0.27, $0.02 better than the analyst estimate of $0.25. Revenue for the quarter came in at $116.7 million versus the consensus estimate of $118.2 million.
For earnings history and earnings-related data on Depomed (DEPO) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abercrombie & Fitch (ANF) Tops Q2 EPS by $2.19, Offers Guidance
- UBS Reiterates Neutral Rating on Brown Forman (BF-B) Ahead of Q1 Earnings
- Williams-Sonoma (WSM) Tops Q2 EPS by 4c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
